| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000038294 |
| Receipt No. | R000043647 |
| Scientific Title | The efficacy of psychological approaches to HIV patients infected through blood products; A randomized, parallel-group comparison exploratory study. |
| Date of disclosure of the study information | 2019/10/20 |
| Last modified on | 2021/05/11 (Ver. 5) |
| Basic information | ||
| Public title | The efficacy of psychotherapy for HIV patients infected through blood products | |
| Acronym | YP-RCT | |
| Scientific Title | The efficacy of psychological approaches to HIV patients infected through blood products; A randomized, parallel-group comparison exploratory study. | |
| Scientific Title:Acronym | YP-RCT | |
| Region |
|
|
| Condition | |||||
| Condition | HIV infection, Hemophilia, von Willebrand disease | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | We evaluate mental health and mood for Focusing-Oriented Therapy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | -Mental health: General Health Questionnaire 28, GHQ-28
-Mood: Profile of mood states(2nd edition), POMS2 |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Focusing Oriented therapy(6 sessions) | |
| Interventions/Control_2 | Conversation with clinical psychologist(3 sessions) and Focusing Oriented therapy(3 sessions) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) HIV patients infected through blood products
2) Over 20 years of age 3) Patient who obtains the agreement of participating in this study |
|||
| Key exclusion criteria | 1) Patient already has received psychotherapy or counseling, and those might be interrupted by receiving this study.
2) Patient not to be able to psychotherapy for severe physical or mental state. 3) Patient who judge not to be able to participate by the principal investigator. |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Center for Global Health and Medicine | ||||||
| Division name | AIDS Clinical Center | ||||||
| Zip code | 162-8655 | ||||||
| Address | Toyama, Shinjyuku-ku Tokyo | ||||||
| TEL | 03-3202-7181 | ||||||
| kkomatsu@acc.ncgm.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Center for Global Health and Medicine | ||||||
| Division name | AIDS Clinical Center | ||||||
| Zip code | 162-8655 | ||||||
| Address | Toyama, Shinjyuku-ku Tokyo | ||||||
| TEL | 03-3202-7181 | ||||||
| Homepage URL | |||||||
| rinrijm@hosp.ncgm.go.jp | |||||||
| Sponsor | |
| Institute | National Center for Global Health and Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Foundation for AIDS Prevention |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Secretariat of Clinical Sciences, National Center for Global Health and Medicine |
| Address | 1-21-1 toyama shinjuku-ku, Tokyo |
| Tel | 03-3202-7181 |
| rinrijm@hosp.ncgm.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立国際医療研究センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 34 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000043647 |